{"organizations": [], "uuid": "db07d6af1c492a118af42ff8f518a30362379d79", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cytori-therapeutics-co-met-with-us/brief-cytori-therapeutics-co-met-with-u-s-fda-to-discuss-outcome-of-star-clinical-trial-idUSFWN1QY0Z7", "country": "US", "domain_rank": 408, "title": "BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-16T23:15:00.000+02:00", "replies_count": 0, "uuid": "db07d6af1c492a118af42ff8f518a30362379d79"}, "author": "", "url": "https://www.reuters.com/article/brief-cytori-therapeutics-co-met-with-us/brief-cytori-therapeutics-co-met-with-u-s-fda-to-discuss-outcome-of-star-clinical-trial-idUSFWN1QY0Z7", "ord_in_thread": 0, "title": "BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-cytori therapeutics - co", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "outcome of star clinical trial reuters", "sentiment": "none"}, {"name": "cytori therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 16, 2018 / 9:15 PM / in 6 minutes BRIEF-Cytori Therapeutics - Co Met With U.S. FDA To Discuss Outcome Of Star Clinical Trial Reuters Staff 1 Min Read March 16 (Reuters) - Cytori Therapeutics Inc: * CYTORI THERAPEUTICS - ON MARCH 1, CO MET WITH U.S. FDA TO DISCUSS OUTCOME OF STAR CLINICAL TRIAL AND COâ€™S PLANS FOR HABEO CELL THERAPY - SEC FILING * CYTORI THERAPEUTICS-INTENDS TO FINALIZE & PURSUE ADDITIONAL DIALOGUE WITH FDA TO CLARIFY PARAMETERS OF FOLLOW-ON CLINICAL TRIAL OF HABEO CELL THERAPY Source text ( bit.ly/2tSzb9l ) Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-16T23:15:00.000+02:00", "crawled": "2018-03-16T23:27:32.068+02:00", "highlightTitle": ""}